言語を選択
新規登録

G4S

お問い合わせ

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Zibotentan/DapagliflozinPhase 3 ClinicalAstrazeneca Ab, AstraZeneca global R & D (China) Co LtdAlbuminuria; Kidney Diseases; Renal Insufficiency, Chronic
詳細
PatecibartGMA-301; GMA-301-A; GMA-301-BPhase 2 ClinicalGmax Biopharm LlcPulmonary Arterial Hypertension
詳細
SC-0062SC-0062Phase 2 ClinicalShijiazhuang Zhikang Hongren New Drug Development Co LtdGlomerulonephritis, IGA; Altitude Sickness; Kidney Diseases; Pulmonary Arterial Hypertension; Diabetic Nephropathies
詳細
ZibotentanZD-4054; AZD-4054Phase 2 ClinicalAstrazeneca PlcHepatic Insufficiency; Scleroderma, Limited; Neoplasm Metastasis; Peripheral Arterial Disease; Carcinoma, Non-Small-Cell Lung; Metastatic breast cancer; Renal Insufficiency, Chronic; Lung Neoplasms; Colorectal Neoplasms; Solid tumours; Prostatic Neoplasms; Hypertension, Portal; Scleroderma, Systemic; Liver Cirrhosis; Intermittent Claudication; Renal Insufficiency; Ovarian Neoplasms; Microvascular Angina
詳細
BQ-123CGS-26343; BQ-123; PMZ-2123Phase 1 ClinicalMidwestern UniversityHypertension, Pulmonary; Heart Failure; ST Elevation Myocardial Infarction; Pain; Diabetic Ketoacidosis; Coronary Artery Disease; Proteinuria; Metabolic Syndrome; Hypoxia, Brain; Hypertension; Cardiovascular Diseases; Renal Insufficiency, Chronic; Multiple System Atrophy; Pure Autonomic Failure
詳細
GMA-131GMA-131Phase 1 ClinicalGmax Biopharm Llc, Gmaxx Biologics LtdDiabetic Nephropathies
詳細
SAL-0120SAL0120; SAL-0120Phase 1 ClinicalShenzhen Salubris Pharmaceuticals Co LtdGlomerulonephritis, IGA; Hypertension; Essential Hypertension
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Clazosentan SodiumRo-61-1790; ACT-108475; AXV-034; VML-588; AXV-034343ApprovedF. Hoffmann-La Roche LtdPivlazJapanSubarachnoid Hemorrhage; Vasospasm, Intracranial; Cerebral Infarction; Brain IschemiaIdorsia Pharmaceuticals Ltd2022-01-20Brain Ischemia; Aneurysm; Vasospasm, Intracranial; Subarachnoid Hemorrhage; Cerebral Infarction
詳細
Macitentan/TadalafilApprovedActelion Pharmaceuticals LtdOPSYNVIUnited StatesPulmonary Arterial HypertensionActelion Pharmaceuticals Us Inc2024-03-22Pulmonary Arterial Hypertension
詳細
AmbrisentanLU-208075; BSF-208075; GSK-132576AApprovedAbbott LaboratoriesLetairis, Volibris, 凡瑞克United StatesPulmonary Arterial HypertensionGilead Sciences Inc2007-06-15Hypertension, Pulmonary; Sarcoidosis; Hypertension, Portal; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis; Thromboembolism; Hypertension; Ascites; Hypoxia; Acute Kidney Injury; Pulmonary Arterial Hypertension; Vascular Diseases; Anemia, Sickle Cell; Hepatorenal Syndrome
詳細
SparsentanRE-021; PS-433540; BMS-346567ApprovedBristol-Myers Squibb CompanyFilspariUnited StatesGlomerulonephritis, IGATravere Therapeutics Inc2023-02-17Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Glomerulonephritis, IGA; Kidney Diseases; Vasculitis; Autoimmune Diseases; Nephrosis, Lipoid; Hypertension; Immune System Diseases; Glomerulosclerosis, Focal Segmental; Cardiovascular Diseases; Nephritis, Hereditary; Glomerulonephritis
詳細
Bosentan HydrateACT-050088; HGP-1206; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039ApprovedF. Hoffmann-La Roche LtdStayveer, 全可利, TracleerUnited StatesPulmonary Arterial HypertensionActelion Pharmaceuticals Ltd2001-11-20Pulmonary Fibrosis; Heart Defects, Congenital; Diabetes Mellitus; Anemia, Sickle Cell; Persistent Fetal Circulation Syndrome; Ulcer; Sleep Apnea Syndromes; Glaucoma; Pulmonary Arterial Hypertension; Hypertension; Hepatopulmonary Syndrome; Hypertension, Pulmonary; Lung Diseases, Interstitial; Sarcoidosis; Liver Cirrhosis; Chronic thromboembolic pulmonary hypertension; Fibrosis; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Diabetes Mellitus, Type 2; Heart Septal Defects, Atrial
詳細
MacitentanACT-064992; Actelion-1; JNJ-67896062ApprovedActelion Pharmaceuticals LtdZependo, Opsumit, 傲朴舒United StatesPulmonary Arterial HypertensionActelion Pharmaceuticals Us Inc2013-10-18Hypertension, Pulmonary; Pulmonary Embolism; Heart Failure, Diastolic; Heart Failure; Scleroderma, Systemic; Chronic thromboembolic pulmonary hypertension; Idiopathic Pulmonary Fibrosis; Glioblastoma; Thromboembolism; Pulmonary Arterial Hypertension; Eisenmenger Complex; Ulcer; Heart Defects, Congenital; Anemia, Sickle Cell; Chronic Disease
詳細
AprocitentanACT-132577; AC-080; JNJ-2820ApprovedIdorsia Pharmaceuticals Ltd, Actelion Pharmaceuticals LtdTRYVIOUnited StatesHypertensionIdorsia Pharmaceuticals Ltd2024-03-19Hypertension; Hepatic Insufficiency; Essential Hypertension; Renal Insufficiency, Chronic
詳細
  • お問い合わせ
  • 市販薬剤に関する情報
  • 治験薬に関する情報
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8